Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers.
Forsberg L, Spelman T, Klyve P, Manouchehrinia A, Ramanujam R, Mouresan E, Drahota J, Horakova D, Joensen H, Pontieri L, Magyari M, Ellenberger D, Stahmann A, Rodgers J, Witts J, Middleton R, Nicholas R, Bezlyak V, Adlard N, Hach T, Lines C, Vukusic S, Soilu-Hänninen M, van der Walt A, Butzkueven H, Iaffaldano P, Trojano M, Glaser A, Hillert J; SPMS Research Collaboration Network. Forsberg L, et al. Among authors: soilu hanninen m. Mult Scler J Exp Transl Clin. 2023 Feb 16;9(1):20552173231153557. doi: 10.1177/20552173231153557. eCollection 2023 Jan-Mar. Mult Scler J Exp Transl Clin. 2023. PMID: 36816812 Free PMC article.
Multiple sclerosis registries in Europe - An updated mapping survey.
Glaser A, Stahmann A, Meissner T, Flachenecker P, Horáková D, Zaratin P, Brichetto G, Pugliatti M, Rienhoff O, Vukusic S, de Giacomoni AC, Battaglia MA, Brola W, Butzkueven H, Casey R, Drulovic J, Eichstädt K, Hellwig K, Iaffaldano P, Ioannidou E, Kuhle J, Lycke K, Magyari M, Malbaša T, Middleton R, Myhr KM, Notas K, Orologas A, Otero-Romero S, Pekmezovic T, Sastre-Garriga J, Seeldrayers P, Soilu-Hänninen M, Stawiarz L, Trojano M, Ziemssen T, Hillert J, Thalheim C. Glaser A, et al. Mult Scler Relat Disord. 2019 Jan;27:171-178. doi: 10.1016/j.msard.2018.09.032. Epub 2018 Oct 4. Mult Scler Relat Disord. 2019. PMID: 30384204 No abstract available.
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis.
Butzkueven H, Hillert J, Soilu-Hänninen M, Ziemssen T, Kuhle J, Wergeland S, Magyari M, Berger JR, Moore N, Aydemir A, Bezemer I, Sabidó M. Butzkueven H, et al. Among authors: soilu hanninen m. Curr Med Res Opin. 2023 Oct;39(10):1367-1374. doi: 10.1080/03007995.2023.2256220. Epub 2023 Sep 7. Curr Med Res Opin. 2023. PMID: 37675878
Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients.
Verkkoniemi-Ahola A, Hartikainen P, Hassi K, Kuusisto H, Lahdenperä S, Mehtälä J, Viitala M, Ylisaukko-Oja T, Soilu-Hänninen M. Verkkoniemi-Ahola A, et al. Among authors: soilu hanninen m. Mult Scler J Exp Transl Clin. 2023 Oct 4;9(4):20552173231204466. doi: 10.1177/20552173231204466. eCollection 2023 Oct-Dec. Mult Scler J Exp Transl Clin. 2023. PMID: 37808458 Free PMC article.
Risk of cancer among Finnish multiple sclerosis patients.
Hongell K, Kurki S, Sumelahti ML, Soilu-Hänninen M. Hongell K, et al. Mult Scler Relat Disord. 2019 Oct;35:221-227. doi: 10.1016/j.msard.2019.08.005. Epub 2019 Aug 5. Mult Scler Relat Disord. 2019. PMID: 31404761
70 results